Michael Sinclair, Director, 10% Owner at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 26,332 shares at $10.90 ($289K) on 2022-06-14, disclosed to the SEC on 2022-06-15.
Open-market sale of $289k OPNT by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.09 | 5,491 | $61K | 21.1% |
| 2 | $11.09 | 5,491 | $61K | 21.1% |
| 3 | $10.90 | 7,225 | $79K | 27.3% |
| 4 | $10.90 | 7,225 | $79K | 27.3% |
| 5 | $10.60 | 900 | $10K | 3.3% |
| Total | $10.97 avg | 26,332 |
| $289K |
| 100% |
| Filing → |
| OPNT | SELL | 2022-06-06 | $549K | — | Filing → |
| OPNT | SELL | 2021-08-25 | $3.6M | — | Filing → |
| OPNT | SELL | 2019-09-13 | $751K | — | Filing → |